rouletteanalyzer| Lepu Bio-B (02157.HK): Three clinical study results announced at the 2024 ASCO Annual Meeting

Gelonghui May 24 丨 Lepu Bio-B (02157rouletteanalyzer.HK) issued an announcementrouletteanalyzer, the company innovates drug candidates and combination therapies (including antibody drug conjugates ("ADC") MRG004A, MRG003 and HX008rouletteanalyzerand the combination therapy of HX008 and nirapali) were announced at the 2024 American Society of Clinical Oncology ("ASCO") Annual Meeting.